{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:51:28Z","timestamp":1787003488201,"version":"build-2736575974"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,28]],"date-time":"2020-07-28T00:00:00Z","timestamp":1595894400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,28]],"date-time":"2020-07-28T00:00:00Z","timestamp":1595894400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Neurofibromatosis type 2 (NF2) is an autosomal dominant Mendelian tumor predisposition disorder caused by germline pathogenic variants in the tumor suppressor\n                    <jats:italic>NF2<\/jats:italic>\n                    . Meningiomas are the second most common neoplasm in NF2, often occurring in multiple intracranial and spinal locations within the same patient. In this prospective longitudinal study, we assessed volumes and growth rates of ten spinal and ten cranial benign meningiomas in seven NF2 patients that concluded with surgical resection and performed whole-exome sequencing and copy-number variant (CNV) analysis of the tumors. Our comparison of the volume and the growth rate of NF2-associated spinal and cranial meningiomas point to the differences in timing of tumor initiation and\/or to the differences in tumor progression (e.g., non-linear, saltatory growth) at these two anatomical locations. Genomic investigation of these tumors revealed that somatic inactivation of\n                    <jats:italic>NF2<\/jats:italic>\n                    is the principal and perhaps the only driver of tumor initiation; and that tumor progression likely occurs via accumulation of CNVs, rather than point mutations. Results of this study contribute to a better understanding of NF2-associated meningiomas clinical behavior and their genetic underpinnings.\n                  <\/jats:p>","DOI":"10.1038\/s41598-020-69074-z","type":"journal-article","created":{"date-parts":[[2020,7,28]],"date-time":"2020-07-28T06:04:50Z","timestamp":1595916290000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Comparative clinical and genomic analysis of neurofibromatosis type 2-associated cranial and spinal meningiomas"],"prefix":"10.1038","volume":"10","author":[{"given":"Alexander","family":"Pemov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramita","family":"Dewan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy F.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Settara C.","family":"Chandrasekharappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhik","family":"Ray-Chaudhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristine","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Heiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James C.","family":"Mullikin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashant","family":"Chittiboina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas R.","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashok R.","family":"Asthagiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,28]]},"reference":[{"key":"69074_CR1","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/ajmg.a.33139","volume":"152A","author":"DG Evans","year":"2010","unstructured":"Evans, D. G. et al. Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service. Am. J. Med. Genet. Part A 152A, 327\u2013332. https:\/\/doi.org\/10.1002\/ajmg.a.33139 (2010).","journal-title":"Am. J. Med. Genet. Part A"},{"key":"69074_CR2","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1097\/00129492-200501000-00016","volume":"26","author":"DGR Evans","year":"2005","unstructured":"Evans, D. G. R. et al. Incidence of vestibular schwannoma and neurofibromatosis 2 in the north west of England over a 10-year period: higher incidence than previously thought. Otol. Neurotol. 26, 93\u201397. https:\/\/doi.org\/10.1097\/00129492-200501000-00016 (2005).","journal-title":"Otol. Neurotol."},{"key":"69074_CR3","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1016\/s0140-6736(09)60259-2","volume":"373","author":"AR Asthagiri","year":"2009","unstructured":"Asthagiri, A. R. et al. Neurofibromatosis type 2. Lancet 373, 1974\u20131986. https:\/\/doi.org\/10.1016\/s0140-6736(09)60259-2 (2009).","journal-title":"Lancet"},{"key":"69074_CR4","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1001\/jama.1997.03550010065042","volume":"278","author":"DH Gutmann","year":"1997","unstructured":"Gutmann, D. H. The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA J. Am. Med. Assoc. 278, 51. https:\/\/doi.org\/10.1001\/jama.1997.03550010065042 (1997).","journal-title":"JAMA J. Am. Med. Assoc."},{"key":"69074_CR5","first-page":"603","volume":"84","author":"DG Evans","year":"1992","unstructured":"Evans, D. G. et al. A clinical study of type 2 neurofibromatosis. Q. J. Med. 84, 603\u2013618 (1992).","journal-title":"Q. J. Med."},{"key":"69074_CR6","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1097\/00006123-199605000-00004","volume":"38","author":"V-F Mautner","year":"1996","unstructured":"Mautner, V.-F. et al. The neuroimaging and clinical spectrum of neurofibromatosis 2. Neurosurgery 38, 880\u2013886. https:\/\/doi.org\/10.1097\/00006123-199605000-00004 (1996).","journal-title":"Neurosurgery"},{"key":"69074_CR7","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1002\/ajmg.1320520411","volume":"52","author":"DM Parry","year":"1994","unstructured":"Parry, D. M. et al. Neurofibromatosis 2 (NF2): clinical characteristics of 63 affected individuals and clinical evidence for heterogeneity. Am. J. Med. Genet. 52, 450\u2013461. https:\/\/doi.org\/10.1002\/ajmg.1320520411 (1994).","journal-title":"Am. J. Med. Genet."},{"key":"69074_CR8","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1093\/neuonc\/nos129","volume":"14","author":"S Goutagny","year":"2012","unstructured":"Goutagny, S. et al. Long-term follow-up of 287 meningiomas in neurofibromatosis type 2 patients: clinical, radiological, and molecular features. Neuro-Oncol. 14, 1090\u20131096. https:\/\/doi.org\/10.1093\/neuonc\/nos129 (2012).","journal-title":"Neuro-Oncol."},{"key":"69074_CR9","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1086\/342716","volume":"71","author":"ME Baser","year":"2002","unstructured":"Baser, M. E. et al. Predictors of the risk of mortality in neurofibromatosis 2. Am. J. Hum. Genet. 71, 715\u2013723. https:\/\/doi.org\/10.1086\/342716 (2002).","journal-title":"Am. J. Hum. Genet."},{"key":"69074_CR10","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1056\/nejm199811123392003","volume":"339","author":"D Kondziolka","year":"1998","unstructured":"Kondziolka, D., Lunsford, L. D., McLaughlin, M. R. & Flickinger, J. C. Long-term outcomes after radiosurgery for acoustic neuromas. N. Engl. J. Med. 339, 1426\u20131433. https:\/\/doi.org\/10.1056\/nejm199811123392003 (1998).","journal-title":"N. Engl. J. Med."},{"key":"69074_CR11","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1002\/ajmg.a.34359","volume":"158a","author":"JO Blakeley","year":"2012","unstructured":"Blakeley, J. O. et al. Consensus recommendations for current treatments and accelerating clinical trials for patients with neurofibromatosis type 2. Am. J. Med. Genet. Part A 158a, 24\u201341. https:\/\/doi.org\/10.1002\/ajmg.a.34359 (2012).","journal-title":"Am. J. Med. Genet. Part A"},{"key":"69074_CR12","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1054\/bjoc.1999.1030","volume":"82","author":"ME Baser","year":"2000","unstructured":"Baser, M. E., Evans, D. G., Jackler, R. K., Sujansky, E. & Rubenstein, A. Neurofibromatosis 2, radiosurgery and malignant nervous system tumours. Br. J. Cancer 82, 998. https:\/\/doi.org\/10.1054\/bjoc.1999.1030 (2000).","journal-title":"Br. J. Cancer"},{"key":"69074_CR13","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.ijrobp.2008.03.073","volume":"73","author":"S Wentworth","year":"2009","unstructured":"Wentworth, S. et al. Clinical experience with radiation therapy in the management of neurofibromatosis-associated central nervous system tumors. Int. J. Radiat. Oncol. Biol. Phys. 73, 208\u2013213. https:\/\/doi.org\/10.1016\/j.ijrobp.2008.03.073 (2009).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"69074_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.wneu.2019.01.042","author":"TR Meling","year":"2019","unstructured":"Meling, T. R., Da Broi, M., Scheie, D., Helseth, E. & Smoll, N. R. Meningioma surgery-are we making progress?. World Neurosurg. https:\/\/doi.org\/10.1016\/j.wneu.2019.01.042 (2019).","journal-title":"World Neurosurg."},{"key":"69074_CR15","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noz039","author":"SJM Rijnen","year":"2019","unstructured":"Rijnen, S. J. M. et al. Cognitive outcomes in meningioma patients undergoing surgery: individual changes over time and predictors of late cognitive functioning. Neuro Oncol. https:\/\/doi.org\/10.1093\/neuonc\/noz039 (2019).","journal-title":"Neuro Oncol."},{"key":"69074_CR16","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1055\/s-0038-1667066","volume":"80","author":"JS Ehresman","year":"2019","unstructured":"Ehresman, J. S. et al. Risk of developing postoperative deficits based on tumor location after surgical resection of an intracranial meningioma. J. Neurolog. Surg. Part B Skull Base 80, 59\u201366. https:\/\/doi.org\/10.1055\/s-0038-1667066 (2019).","journal-title":"J. Neurolog. Surg. Part B Skull Base"},{"key":"69074_CR17","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s11060-018-2993-3","volume":"140","author":"L Hua","year":"2018","unstructured":"Hua, L. et al. Clinical and prognostic features of spinal meningioma: a thorough analysis from a single neurosurgical center. J. Neurooncol. 140, 639\u2013647. https:\/\/doi.org\/10.1007\/s11060-018-2993-3 (2018).","journal-title":"J. Neurooncol."},{"key":"69074_CR18","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1007\/s00586-008-0685-y","volume":"17","author":"IE Sandalcioglu","year":"2008","unstructured":"Sandalcioglu, I. E. et al. Spinal meningiomas: critical review of 131 surgically treated patients. Eur. Spine J. 17, 1035\u20131041. https:\/\/doi.org\/10.1007\/s00586-008-0685-y (2008).","journal-title":"Eur. Spine J."},{"key":"69074_CR19","doi-asserted-by":"publisher","first-page":"E14","DOI":"10.3171\/foc-07\/10\/e14","volume":"23","author":"M Setzer","year":"2007","unstructured":"Setzer, M., Vatter, H., Marquardt, G., Seifert, V. & Vrionis, F. D. Management of spinal meningiomas: surgical results and a review of the literature. Neurosurg. Focus 23, E14. https:\/\/doi.org\/10.3171\/foc-07\/10\/e14 (2007).","journal-title":"Neurosurg. Focus"},{"key":"69074_CR20","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1227\/00006123-198908000-00001","volume":"25","author":"CL Solero","year":"1989","unstructured":"Solero, C. L. et al. Spinal meningiomas: review of 174 operated cases. Neurosurgery 25, 153\u2013160 (1989).","journal-title":"Neurosurgery"},{"key":"69074_CR21","doi-asserted-by":"publisher","first-page":"804","DOI":"10.3171\/jns.1982.57.6.0804","volume":"57","author":"WJ Levy Jr","year":"1982","unstructured":"Levy, W. J. Jr., Bay, J. & Dohn, D. Spinal cord meningioma. J. Neurosurg. 57, 804\u2013812. https:\/\/doi.org\/10.3171\/jns.1982.57.6.0804 (1982).","journal-title":"J. Neurosurg."},{"key":"69074_CR22","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3171\/2012.3.Jns111649","volume":"117","author":"MS Dirks","year":"2012","unstructured":"Dirks, M. S. et al. Long-term natural history of neurofibromatosis type 2-associated intracranial tumors. J. Neurosurg. 117, 109\u2013117. https:\/\/doi.org\/10.3171\/2012.3.Jns111649 (2012).","journal-title":"J. Neurosurg."},{"key":"69074_CR23","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1097\/01.jnen.0000229234.13372.d8","volume":"65","author":"JM Sayagu\u00e9s","year":"2006","unstructured":"Sayagu\u00e9s, J. M. et al. Microarray-based analysis of spinal versus intracranial meningiomas: different clinical, biological, and genetic characteristics associated with distinct patterns of gene expression. J. Neuropathol. Exp. Neurol. 65, 445\u2013454. https:\/\/doi.org\/10.1097\/01.jnen.0000229234.13372.d8 (2006).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"69074_CR24","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s11060-004-2749-0","volume":"70","author":"A Perry","year":"2004","unstructured":"Perry, A., Gutmann, D. H. & Reifenberger, G. Molecular pathogenesis of meningiomas. J. Neurooncol. 70, 183\u2013202. https:\/\/doi.org\/10.1007\/s11060-004-2749-0 (2004).","journal-title":"J. Neurooncol."},{"key":"69074_CR25","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/ng.2526","volume":"45","author":"PK Brastianos","year":"2013","unstructured":"Brastianos, P. K. et al. Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations. Nat. Genet. 45, 285\u2013289. https:\/\/doi.org\/10.1038\/ng.2526 (2013).","journal-title":"Nat. Genet."},{"key":"69074_CR26","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1126\/science.1233009","volume":"339","author":"VE Clark","year":"2013","unstructured":"Clark, V. E. et al. Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO. Science 339, 1077\u20131080. https:\/\/doi.org\/10.1126\/science.1233009 (2013).","journal-title":"Science"},{"key":"69074_CR27","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1038\/ng.3651","volume":"48","author":"VE Clark","year":"2016","unstructured":"Clark, V. E. et al. Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas. Nat. Genet. 48, 1253\u20131259. https:\/\/doi.org\/10.1038\/ng.3651 (2016).","journal-title":"Nat. Genet."},{"key":"69074_CR28","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s00401-013-1093-x","volume":"125","author":"DE Reuss","year":"2013","unstructured":"Reuss, D. E. et al. Secretory meningiomas are defined by combined KLF4 K409Q and TRAF7 mutations. Acta Neuropathol. 125, 351\u2013358. https:\/\/doi.org\/10.1007\/s00401-013-1093-x (2013).","journal-title":"Acta Neuropathol."},{"key":"69074_CR29","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.15043","author":"M Tang","year":"2017","unstructured":"Tang, M. et al. Whole-genome sequencing identifies new genetic alterations in meningiomas. Oncotarget. https:\/\/doi.org\/10.18632\/oncotarget.15043 (2017).","journal-title":"Oncotarget."},{"key":"69074_CR30","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.1101\/gad.194027.112","volume":"26","author":"AM Hebert","year":"2012","unstructured":"Hebert, A. M., DuBoff, B., Casaletto, J. B., Gladden, A. B. & McClatchey, A. I. Merlin\/ERM proteins establish cortical asymmetry and centrosome position. Genes Dev. 26, 2709\u20132723. https:\/\/doi.org\/10.1101\/gad.194027.112 (2012).","journal-title":"Genes Dev."},{"key":"69074_CR31","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1242\/dmm.004507","volume":"3","author":"P Hernandez","year":"2010","unstructured":"Hernandez, P. & Tirnauer, J. S. Tumor suppressor interactions with microtubules: keeping cell polarity and cell division on track. Dis. Models Mech. 3, 304\u2013315. https:\/\/doi.org\/10.1242\/dmm.004507 (2010).","journal-title":"Dis. Models Mech."},{"key":"69074_CR32","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1534\/genetics.107.081570","volume":"178","author":"T Shimizu","year":"2008","unstructured":"Shimizu, T., Ho, L. L. & Lai, Z. C. The mob as tumor suppressor gene is essential for early development and regulates tissue growth in drosophila. Genetics 178, 957\u2013965. https:\/\/doi.org\/10.1534\/genetics.107.081570 (2008).","journal-title":"Genetics"},{"key":"69074_CR33","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.celrep.2013.07.009","volume":"4","author":"A Ettahar","year":"2013","unstructured":"Ettahar, A. et al. Identification of PHRF1 as a tumor suppressor that promotes the TGF-\u03b2 cytostatic program through selective release of TGIF-driven PML inactivation. Cell Rep. 4, 530\u2013541. https:\/\/doi.org\/10.1016\/j.celrep.2013.07.009 (2013).","journal-title":"Cell Rep."},{"key":"69074_CR34","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1038\/onc.2013.111","volume":"33","author":"W Zhou","year":"2013","unstructured":"Zhou, W. & Bao, S. PML-mediated signaling and its role in cancer stem cells. Oncogene 33, 1475\u20131484. https:\/\/doi.org\/10.1038\/onc.2013.111 (2013).","journal-title":"Oncogene"},{"key":"69074_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-017-3127-6","author":"R Dewan","year":"2017","unstructured":"Dewan, R. et al. First insight into the somatic mutation burden of neurofibromatosis type 2-associated grade I and grade II meningiomas: a case report comprehensive genomic study of two cranial meningiomas with vastly different clinical presentation. BMC Cancer. https:\/\/doi.org\/10.1186\/s12885-017-3127-6 (2017).","journal-title":"BMC Cancer."},{"key":"69074_CR36","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/ng.2552","volume":"45","author":"MJ Smith","year":"2013","unstructured":"Smith, M. J. et al. Loss-of-function mutations in SMARCE1 cause an inherited disorder of multiple spinal meningiomas. Nat. Genet. 45, 295\u2013298. https:\/\/doi.org\/10.1038\/ng.2552 (2013).","journal-title":"Nat. Genet."},{"key":"69074_CR37","doi-asserted-by":"publisher","first-page":"21715","DOI":"10.1073\/pnas.1912858116","volume":"116","author":"AJ Patel","year":"2019","unstructured":"Patel, A. J. et al. Molecular profiling predicts meningioma recurrence and reveals loss of DREAM complex repression in aggressive tumors. Proc. Natl. Acad. Sci. USA 116, 21715\u201321726. https:\/\/doi.org\/10.1073\/pnas.1912858116 (2019).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"69074_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11111633","author":"S Lee","year":"2019","unstructured":"Lee, S. et al. The role of merlin\/NF2 loss in meningioma biology. Cancer https:\/\/doi.org\/10.3390\/cancers11111633 (2019).","journal-title":"Cancer"},{"key":"69074_CR39","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1080\/14737175.2018.1429920","volume":"18","author":"C Apra","year":"2018","unstructured":"Apra, C., Peyre, M. & Kalamarides, M. Current treatment options for meningioma. Expert Rev. Neurother. 18, 241\u2013249. https:\/\/doi.org\/10.1080\/14737175.2018.1429920 (2018).","journal-title":"Expert Rev. Neurother."},{"key":"69074_CR40","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/13543784.2020.1740680","volume":"29","author":"A Mohanty","year":"2020","unstructured":"Mohanty, A. et al. FAK-targeted and combination therapies for the treatment of cancer: an overview of phase I and II clinical trials. Expert Opin. Investig. Drugs 29, 399\u2013409. https:\/\/doi.org\/10.1080\/13543784.2020.1740680 (2020).","journal-title":"Expert Opin. Investig. Drugs"},{"key":"69074_CR41","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1148\/radiol.2331021332","volume":"233","author":"EW Wallace","year":"2004","unstructured":"Wallace, E. W. The dural tail sign. Radiology 233, 56\u201357. https:\/\/doi.org\/10.1148\/radiol.2331021332 (2004).","journal-title":"Radiology"},{"key":"69074_CR42","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1101\/gr.106716.110","volume":"20","author":"JK Teer","year":"2010","unstructured":"Teer, J. K. et al. Systematic comparison of three genomic enrichment methods for massively parallel DNA sequencing. Genome Res. 20, 1420\u20131431. https:\/\/doi.org\/10.1101\/gr.106716.110 (2010).","journal-title":"Genome Res."},{"key":"69074_CR43","doi-asserted-by":"publisher","first-page":"e164","DOI":"10.1093\/nar\/gkq603","volume":"38","author":"K Wang","year":"2010","unstructured":"Wang, K., Li, M. & Hakonarson, H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 38, e164\u2013e164. https:\/\/doi.org\/10.1093\/nar\/gkq603 (2010).","journal-title":"Nucleic Acids Res."},{"key":"69074_CR44","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1093\/bioinformatics\/btr711","volume":"28","author":"JK Teer","year":"2011","unstructured":"Teer, J. K., Green, E. D., Mullikin, J. C. & Biesecker, L. G. VarSifter: visualizing and analyzing exome-scale sequence variation data on a desktop computer. Bioinformatics 28, 599\u2013600. https:\/\/doi.org\/10.1093\/bioinformatics\/btr711 (2011).","journal-title":"Bioinformatics"},{"key":"69074_CR45","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nbt.2514","volume":"31","author":"K Cibulskis","year":"2013","unstructured":"Cibulskis, K. et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat. Biotechnol. 31, 213\u2013219. https:\/\/doi.org\/10.1038\/nbt.2514 (2013).","journal-title":"Nat. Biotechnol."},{"key":"69074_CR46","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1093\/bioinformatics\/btr665","volume":"28","author":"DE Larson","year":"2011","unstructured":"Larson, D. E. et al. SomaticSniper: identification of somatic point mutations in whole genome sequencing data. Bioinformatics 28, 311\u2013317. https:\/\/doi.org\/10.1093\/bioinformatics\/btr665 (2011).","journal-title":"Bioinformatics"},{"key":"69074_CR47","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1093\/bioinformatics\/btt183","volume":"29","author":"NF Hansen","year":"2013","unstructured":"Hansen, N. F., Gartner, J. J., Mei, L., Samuels, Y. & Mullikin, J. C. Shimmer: detection of genetic alterations in tumors using next-generation sequence data. Bioinformatics 29, 1498\u20131503. https:\/\/doi.org\/10.1093\/bioinformatics\/btt183 (2013).","journal-title":"Bioinformatics"},{"key":"69074_CR48","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1002\/humu.22033","volume":"33","author":"KV Fuentes Fajardo","year":"2012","unstructured":"Fuentes Fajardo, K. V. et al. Detecting false-positive signals in exome sequencing. Hum. Mutat. 33, 609\u2013613. https:\/\/doi.org\/10.1002\/humu.22033 (2012).","journal-title":"Hum. Mutat."},{"key":"69074_CR49","doi-asserted-by":"publisher","first-page":"3168","DOI":"10.1038\/onc.2016.464","volume":"36","author":"A Pemov","year":"2017","unstructured":"Pemov, A. et al. The primacy of NF1 loss as the driver of tumorigenesis in neurofibromatosis type 1-associated plexiform neurofibromas. Oncogene 36, 3168\u20133177. https:\/\/doi.org\/10.1038\/onc.2016.464 (2017).","journal-title":"Oncogene"},{"key":"69074_CR50","volume-title":"Next Generation Microarray Bioinformatics 57\u201372","author":"PV Loo","year":"2011","unstructured":"Loo, P. V. et al. Next Generation Microarray Bioinformatics 57\u201372 (Humana Press, Totowa, 2011)."},{"key":"69074_CR51","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1093\/neuonc\/nou317","volume":"17","author":"R Dewan","year":"2014","unstructured":"Dewan, R. et al. Evidence of polyclonality in neurofibromatosis type 2\u2013associated multilobulated vestibular schwannomas. Neuro-Oncol. 17, 566\u2013573. https:\/\/doi.org\/10.1093\/neuonc\/nou317 (2014).","journal-title":"Neuro-Oncol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-69074-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-69074-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-69074-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T09:35:37Z","timestamp":1670319337000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-69074-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,28]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["69074"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-69074-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,28]]},"assertion":[{"value":"2 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"DRS performs contract clinical telegenetics services for Genome Medical, Inc, in accordance with relevant NCI ethics policies.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12563"}}